Company: BDRX
Filing Date: 2025-09-26
Form Type: F-3
Source: 0001214659-25-014255
Chunk: 105

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-09-26
Form: F-3
Chunk 105
---
 offer under this prospectus, as well as any related free writing prospectuses
and the complete unit agreement and any supplemental agreements that contain the terms of the units.

General

We may issue units consisting
of any combination of the other types of securities offered under this prospectus in one or more series. Each unit will be issued so that
the holder of the unit is also the holder of each security included in the unit. Thus, the holder of a unit will have the rights and obligations
of a holder of each security included in the unit. The unit agreement under which a unit is issued may provide that the securities included
in the unit may not be held or transferred separately, at any time or at any time before a specified date.

We will describe in the applicable
prospectus supplement the terms of the series of units being offered, including:

| · | the designation and terms of the units and of the securities comprising the units, including whether and 
 under what circumstances those securities may be held or transferred separately;                         |

| · | any provisions of the governing unit agreement that differ from those described below; and |

| · | any provisions for the issuance, payment, settlement, transfer or exchange of the units or of the securities 
 comprising the units.                                                                                        |

The provisions described in
this section, as well as those set forth in any prospectus supplement or as described under “Description of Share Capital,”
“Description of American Depositary Shares,” “Description of Debt Securities,” “Description of Warrants”
and “Description of Rights” will apply to each unit, as applicable, and to any Ordinary Shares, including Ordinary Shares
represented by Depositary Shares, debt security, warrant or right included in each unit, as applicable.

Unit Agent

The name and address of the
unit agent, if any, for any units we offer will be set forth in the applicable prospectus supplement.

Issuance in Series

We may issue units in such
amounts and in such numerous distinct series as we determine.

Enforceability of Rights by Holders of Units

Each unit agent will act solely
as our agent under the applicable unit agreement and will not assume any obligation or relationship of agency or trust with any holder
of any unit. A single bank or trust company may act as a unit agent for more than one series of units. A unit agent will have no duty
or responsibility in case of any default by us under the applicable unit agreement or unit, including any duty or responsibility to initiate
any proceedings at